Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers: A matched-pair analysis-Reference-Cited by-同舟云学术

Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers: A matched-pair analysis

Published:2015-09 Issue:9 Volume:33 Page:386.e15-386.e21
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Niwa Naoya,Matsumoto Kazuhiro,Hayakawa Nozomi,Ito Yujiro,Maeda Takahiro,Akatsuka Seiya,Masuda Takeshi,Nakamura So,Tanaka Nobuyuki

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference12 articles.

1. Epidemiology and risk factors of urothelial bladder cancer;Burger;Eur Urol,2013

2. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013;Babjuk;Eur Urol,2013

3. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

4. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update;Hall;J Urol,2007

5. The community-based morbidity of flexible cystoscopy;Burke;BJU Int,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geriatric nutritional risk index as a prognostic factor in elderly patients with non-muscle-invasive bladder cancer: a propensity score-matched study;International Urology and Nephrology;2024-01-04

2. Xpert Bladder Cancer Monitor for the Early Detection of Non-Muscle Invasive Bladder Cancer Recurrences: Could Cystoscopy Be Substituted?;Cancers;2023-07-19

3. Socio-economic burden of disease: Survivorship costs for bladder cancer;Journal of Cancer Policy;2022-06

4. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ);European Urology;2022-01

5. Optimal intervals for follow-up cystoscopy in non-muscle invasive bladder cancer: a systematic review regarding oncological safety;Scandinavian Journal of Urology;2021-12-16